Pharma Marketing Network

OCTOBER 31, 2023

The pharmaceutical industry is increasingly turning to e-commerce to reach new customers and expand their sales. E-commerce strategies are essential for pharmaceutical companies to maximize their online sales and stay ahead of the competition. Companies must ensure that their website is secure and compliant with industry regulations.

Sales 52

Sales Engineer Regulation Marketing 52

Pharmaceutical Technology

NOVEMBER 21, 2022

Japan is currently the fourth largest market in the world. Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Other reasons include lower sales demand and high investment costs.

Marketing 173

Marketing Sales Manufacturing Drugs 173

pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Virtual connections. Engagement channels. Joanna Carlish.

Regulation 91

Regulation Marketing Sales Branding 91

Pharma Marketing Network

OCTOBER 1, 2024

Pharma marketing strategies have evolved significantly over the years, adapting to changes in technology, regulatory landscapes, and consumer behavior. This article provides a comprehensive overview of the various facets of pharmaceutical marketing, from its historical evolution to future trends.

Marketing 52

Marketing Pharma Companies Regulation Production 52

pharmaphorum

DECEMBER 28, 2022

Selling amid a global pandemic has changed the face of sales forever. This is nowhere more pronounced than for medical device sales teams, who typically schedule regular visits to hospitals and doctors’ offices to create a personal, ongoing connection that drives forward the sales process.

Sales 98

Sales Doctors Doctor Production 98

Pharmaceutical Technology

JULY 26, 2022

According to GlobalData’s recent Niemann-Pick Type C (NPC): Opportunity Analysis and Forecast to 2031 report, the NPC market is expected to see significant growth during 2021–31. This sales growth will be in line with a steadily increasing disease prevalence and the entrance of novel agents into the market.

Marketing 306

Marketing Gene Branding Clinical Development 306

Pharma Marketing Network

JULY 12, 2023

The pharmaceutical industry is facing a number of challenges, including increasing competition, rising costs, and changing regulations. In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. They are individuals with unique needs, concerns, and experiences.

Marketing 98

Marketing Compliance Regulation Branding 98

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical companies hold permission to market their products directly to consumers. The direct-to-consumer marketing companies for pharmaceuticals are increasingly moving online as it supports the digitisation of information, enabling patients to take control of their health. No product is mentioned for help-seeking advertising.

Marketing 130

Marketing Compliance Production Doctors 130

Pharmaceutical Technology

NOVEMBER 21, 2022

Japan is currently the fourth largest market in the world. Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Other reasons include lower sales demand and high investment costs.

Marketing 130

Marketing Sales Manufacturing Drugs 130

pharmaphorum

OCTOBER 11, 2022

An explosion of digital mental health tools being offered for sale has presented regulators with a problem – how should they be classified and assessed for safety or efficacy? ” The post Wellcome funds work on regulating digital mental health tools appeared first on. . The healthcare charity is providing £1.8

Regulation 107

Regulation Production Development Sales 107

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 195

Manufacturing Marketing Pharma Companies Vaccine 195

Pharma Marketing Network

OCTOBER 14, 2023

In this article, we will explore the challenges of balancing privacy concerns with targeted ads in pharma marketing. In many countries, there are laws in place that regulate the use of personal data. This can help companies reach more potential customers and increase their sales.

Marketing 97

Marketing Compliance Sales Production 97

XTalks

DECEMBER 19, 2023

In the fast-evolving pharmaceutical landscape, tracking the top-selling drugs offers valuable insights into trends, healthcare priorities and the dynamics of the global market. As we approach the end of 2023, a retrospective look at the statistics from 2022 reveals the top 20 drugs dominating retail sales. billion in sales in 2022.

Sales 64

Sales FDA Approval Drugs Vaccine 64

pharmaphorum

JULY 29, 2021

billion in sales from its COVID-19 vaccine Vaxzevria in the first half of this year, but making it available at no profit had weighed on its profit margins. A delayed FDA filing – held up by data requests from the US regulator – should take place before the end of the year, according to the CEO. billion from its one-dose vaccine.

Sales 98

Sales Vaccine Vaccination Regulation 98

BioTech 365

APRIL 7, 2021

Beiersdorf Aktiengesellschaft / Key word(s): Development of Sales Beiersdorf Aktiengesellschaft: Sales growth in the first quarter of 2021 above capital markets expectations 07-Apr-2021 / 14:24 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) … Continue reading →

Sales 40

Sales Marketing Regulation Development 40

XTalks

SEPTEMBER 12, 2022

Food and beverage companies across the supply chain must always be prepared for new regulatory developments in 2022 as they seek to bring new ingredients and products to market. New regulations are often reflective of the supply chain, food safety and consumer trends. Regulating Heavy Metals in Baby Food.

Regulation 52

Regulation Production Contamination Marketing 52

BioPharma Reporter

APRIL 25, 2024

Back in 2014, AstraZeneca and Merck were the first to receive FDA approval for their PARP inhibitor Lynparza (olaparib) for use in breast cancer gene (BRCA)-mutated metastatic ovarian cancer patients.

FDA Approval 98

FDA Approval Sales Gene Marketing 98

XTalks

JULY 7, 2023

Earlier this week, the World Health Organization (WHO) released new guidelines that emphasized the critical role that marketers must play in safeguarding children’s health. The WHO underscored the need for tighter regulations to protect children from the adverse effects of food marketing.

Marketing 78

Marketing Production Regulation Branding 78

Pharmaceutical Technology

SEPTEMBER 15, 2022

Packaging plays a vital role in maintaining the quality, safety, user-friendliness and marketability of drugs and other pharmaceutical products. Finding the best commercial packaging suppliers in contract marketing. Finding the best commercial packaging suppliers in contract marketing.

Packaging 130

Packaging Packaging Marketing Containment 130

pharmaphorum

AUGUST 8, 2022

As we reported this morning, the deal gives Pfizer already-approved SCD therapy Oxbryta (voxelator) – which industry watchers reckon could see a dramatic uptick in sales with Pfizer’s marketing muscle – plus a phase 3 antibody candidate, a phase 1 follow-up to Oxbryta that could offer improved dosing.

Marketing 110

Marketing Sales Gene Editing Antibody 110

Outsourcing Pharma

SEPTEMBER 8, 2023

has seen sales grow by triple digits and has received more than 100 orders since its launch in March 2022. A benchtop DNA sequencer developed by the U.S. DNA sequencing company Element Biosciences, Inc.,

DNA 85

DNA Sales Development Regulation 85

BioPharma Reporter

AUGUST 1, 2022

GSKâs first quarter following the demerger of its consumer health business sees the company raise its 2022 sales guidance to between 6-8%, up from 5-7% on its previous estimation.

Sales 98

Sales Regulation Marketing 98

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Capturing market share. Better customer experience. billion in 2021 to $9.23

Marketing 98

Marketing Life Science Sales Branding 98

Pharma Marketing Network

OCTOBER 3, 2024

In the rapidly evolving landscape of pharmaceutical marketing, Pay-Per-Click (PPC) advertising has emerged as a pivotal tool for reaching targeted audiences efficiently. Understanding PPC analytics in the context of pharma marketing is crucial for optimizing campaigns and ensuring a high return on investment.

Marketing 52

Marketing Regulation Compliance Sales 52

BioPharma Reporter

JANUARY 18, 2024

Despite the current Bruton tyrosine kinase (BTK) inhibitor market being valued at approximately $6 billion, sales specifically for chronic lymphocytic leukemia (CLL) are predicted to be nearly $5 billion by 2032 in the seven major markets.

Marketing 52

Marketing Sales Regulation 52

Pharmaceutical Technology

JUNE 21, 2023

Ketarx will be marketed under the FDA-approved label of ketamine and in dosages that include 10mg/ml, 50mg/ml and 100mg/ml, with the option to boost the concentration and ready-to-administer applications. PharmaTher and Vitruvias Therapeutics have entered a collaboration deal to commercialise PharmaTher’s Ketarx (racemic ketamine) in the US.

FDA Approval 130

FDA Approval Sales Marketing Regulation 130

pharmaphorum

APRIL 30, 2021

It’s fair to say this is the most interesting time ever for market access. A recent analysis delves into the challenges companies face in getting digital health technologies reimbursed and presents recommendations for how they can find a smoother path to market. Time for a NICE change. How will NICE fare in a post-Brexit world?

Marketing 94

Marketing Sales Regulation Drugs 94

pharmaphorum

OCTOBER 28, 2022

The EU regulator has formally started an accelerated assessment of GSK’s RSV vaccine RSVPreF3 OA for older adults, with a decision now expected in the third quarter of next year – a timeline that could allow GSK to beat rival RSV shot developers, including Pfizer, to the European market.

Regulation 52

Regulation Vaccine Vaccination Sales 52

FDA Law Blog

JUNE 12, 2023

By Riëtte van Laack — FDA regulates pet food similar to other animal foods. As anyone familiar with pet (and other animal) food regulation knows, many states require premarket label review and approval and registration of the manufacturer/distributor and/or product for a fee.

Regulation 44

Regulation Production Cosmetics Sales 44

pharmaphorum

NOVEMBER 22, 2022

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market. Sales have been modest to date – just £36 million in the third quarter – despite it being the first drug targeting BCMA to reach the market.

Marketing 105

Marketing Trials Antibody Clinical Trials 105

Pharma Marketing Network

OCTOBER 14, 2024

In the ever-evolving landscape of pharmaceutical marketing, the traditional methods of reaching healthcare professionals and consumers are gradually being supplemented by innovative digital strategies. This includes clear disclosures of any financial or material relationships between the influencer and the brand.

Marketing 52

Marketing Branding Pharma Companies Production 52

XTalks

JANUARY 31, 2023

The US Department of Agriculture (USDA) recently updated its organic food regulations to tighten guidelines around organic products. Oftentimes, when dealing with imports and exports of “organic” products, bills of sales and documents may be forged somewhere along the way, resulting in fraudulent labeling and mislead consumers.

Regulation 52

Regulation Production Bacteria Packaging 52

Pharma Marketing Network

AUGUST 9, 2023

The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Marketing 52

Marketing Compliance Packaging Packaging 52

Pharma in Brief

MAY 4, 2023

The Ontario Superior Court ( ONSC ) has dismissed a claim for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the Regulations ) brought by Apotex Inc. Apotex ) for lost sales of its Apo-Atomoxetine product. Canadian Patent No. Apotex filed an ANDS for its generic Apo-Atomoxetine product.

Regulation 52

Regulation Sales Production Marketing 52

World of DTC Marketing

FEBRUARY 7, 2022

According to Endpoint News” We’ve seen Biogen’s CSO exit under pressure in recent weeks, and senior marketing execs leave in an exodus as the company recoiled from a fierce backlash against the FDA’s ultra controversial approval of Aduhelm for Alzheimer’s. Finally, they need to withdraw Aduhelm from the market.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

FDA Law Blog

SEPTEMBER 26, 2023

(HP&M), a leader in providing legal and regulatory support to the life sciences industries, today announced the appointment of Jeff Grizzel to the newly created position of Chief Marketing Officer (CMO). Jeff joins HP&M from Compliance Architects where he served as Vice President of Business Development.

Marketing 57

Marketing Life Science Business Development Compliance 57

pharmaphorum

DECEMBER 7, 2020

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. Developing market specialist Dr Zulf Masters OBE takes us through the nuances of being successful in this region.

Marketing 92

Marketing Regulation Production Medicine 92